Leilei Fang Changqin Liu Xiaomin Sun Zhanju Liu
10.3389/fonc.2022.925964
Front Oncol
2022 Jun 23;12:925964.
anti-tumor necrosis factor-α colitis durvalumab immune checkpoint inhibitor programmed cell death ligand 1 vedolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/35814408/
Case Reports
PMC9259980
35814408
Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis
2022